A cost comparison of beta 2-agonist bronchodilators is not a cost-effectiveness comparison.
Rickard
K
K
Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA.
Cox
F
F
Okamoto
L
L
Mills
R
R
D000318:Adrenergic beta-Agonists / Q000191:economics* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000191:economics*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards
D000318:Adrenergic beta-Agonists